The discovery that increased levels of cyclin D1 and cyclin E promote cell growth by shortening the G1 phase (Resnitzky et al, 1994) led to the postulation that overexpression of those cyclins is positively involved in carcinogenesis and possibly in clinical tumour aggressiveness. This evidence concerns the gene CCND1 and neoplasm.